CN Patent

CN121843690A — 用于递送治疗性肽的组合物和方法

Assigned to Leland Stanford Junior University · Expires 2026-04-10 · 0y expired

What this patent protects

本文公开了用于递送治疗性肽的组合物和方法。在一些实施方案中，例如，用于治疗疾病或病况的组合物包含动态水凝胶和由动态水凝胶封装的酰化肽。动态水凝胶可以包含聚合物和多个纳米颗粒。聚合物可以与多个纳米颗粒非共价交联。

USPTO Abstract

本文公开了用于递送治疗性肽的组合物和方法。在一些实施方案中，例如，用于治疗疾病或病况的组合物包含动态水凝胶和由动态水凝胶封装的酰化肽。动态水凝胶可以包含聚合物和多个纳米颗粒。聚合物可以与多个纳米颗粒非共价交联。

Drugs covered by this patent

Patent Metadata

Patent number
CN121843690A
Jurisdiction
CN
Classification
—
Expires
2026-04-10
Drug substance claim
No
Drug product claim
No
Assignee
Leland Stanford Junior University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.